新型冠状病毒的神经免疫药理学。
The Neuroimmune Pharmacology of SARS-CoV-2.
机构信息
Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA.
Department of Anesthesiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
出版信息
J Neuroimmune Pharmacol. 2021 Dec;16(4):699-705. doi: 10.1007/s11481-021-10038-z. Epub 2021 Dec 22.
This guest commentary introduces "The Neuroimmune Pharmacology of SARS-CoV-2," a special theme issue for The Journal of Neuroimmune Pharmacology led by the Society on NeuroImmune Pharmacology. The issue builds on the Society's Virtual Workshop on COVID-19 held April 9, 2021. Top row from left: Drs. Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack; Bottom row from left: Drs. Gurudutt Pendyala, Sanjay Maggirwar, and Sulie L. Chang.
这篇评论文章介绍了《神经免疫药理学中的 SARS-CoV-2》，这是神经免疫药理学学会为《神经免疫药理学杂志》主办的一个特别主题专刊。该专刊是基于学会于 2021 年 4 月 9 日举办的 COVID-19 虚拟研讨会。从左至右依次为：桑托什·库马尔博士、索米亚·耶拉马尼奇利博士、潘卡杰·塞思博士、珍·M·比德拉克博士；从左至右依次为：古鲁杜特·彭迪拉博士、桑杰·马格吉瓦尔博士和苏利·L·张博士。
Zotero 插件